Ferrostatin-1 protects HT-22 cells from oxidative toxicity

• Published in: Neural regeneration research Vol. 15; no. 3; pp. 528 - 536
• Main Authors: Chu, Jun, Liu, Chen-Xu, Song, Rui, Li, Qing-Lin
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.03.2020; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Xin’an Key Laboratory of Medicine, Ministry of Education, Anhui University of Chinese Medicine, Hefei, Anhui Province, China; Wolters Kluwer - Medknow; Wolters Kluwer Medknow Publications
• Subjects: Amino acids; Apoptosis; Biochemistry; Cell death; Dehydrogenases; ferroptosis; ferrostatin-1; glutamate; glutathione peroxidase 4; HT-22 cell; oxidative toxicity; prostaglandin peroxidase synthase 2; reactive oxygen species; Glutamate; Health aspects; Lipids; Measurement; Morphology; Necrosis; Nervous system diseases; Neurodegenerative diseases; Neurons; Neurotoxicity; Oxidative stress; Prevention; Reactive oxygen species; Risk factors; Signal transduction; Sorafenib; Statins; Testing; Toxicity; China; United States > US; Japan; glutathione peroxidase 4; ferroptosis; prostaglandin peroxidase synthase 2; reactive oxygen species; ferrostatin-1; HT-22 cell; glutamate; oxidative toxicity
• ISSN: 1673-5374; 1876-7958
• DOI: 10.4103/1673-5374.266060

Ferroptosis is a type of programmed cell death dependent on iron. It is different from other forms of cell death such as apoptosis, classic necrosis and autophagy. Ferroptosis is involved in many neurodegenerative diseases. The role of ferroptosis in glutamate-induced neuronal toxicity is not fully understood. To test its toxicity, glutamate (1.25-20 mM) was applied to HT-22 cells for 12 to 48 hours. The optimal experimental conditions occurred at 12 hours after incubation with 5 mM glutamate. Cells were cultured with 3-12 μM ferrostatin-1, an inhibitor of ferroptosis, for 12 hours before exposure to glutamate. The cell viability was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Autophagy was determined by monodansylcadaverine staining and apoptosis by caspase 3 activity. Damage to cell structures was observed under light and by transmission electron microscopy. The release of lactate dehydrogenase was detected by the commercial kit. Reactive oxygen species were measured by flow cytometry. Glutathione peroxidase activity, superoxide dismutase activity and malondialdehyde level were detected by the appropriate commercial kit. Prostaglandin peroxidase synthase 2 and glutathione peroxidase 4 gene expression was detected by real-time quantitative polymerase chain reaction. Glutathione peroxidase 4 and nuclear factor erythroid-derived-like 2 protein expression was detected by western blot analysis. Results showed that ferrostatin-1 can significantly counter the effects of glutamate on HT-22 cells, improving the survival rate, reducing the release of lactate dehydrogenase and reducing the damage to mitochondrial ultrastructure. However, it did not affect the caspase-3 expression and monodansylcadaverine-positive staining in glutamate-injured HT-22 cells. Ferrostatin-1 reduced the levels of reactive oxygen species and malondialdehyde and enhanced superoxide dismutase activity. It decreased gene expression of prostaglandin peroxidase synthase 2 and increased gene expression of glutathione peroxidase 4 and protein expressions of glutathione peroxidase 4 and nuclear factor (erythroid-derived)-like 2 in glutamate-injured HT-22 cells. Treatment of cultured cells with the apoptosis inhibitor Z-Val-Ala-Asp (OMe)-fluoromethyl ketone (2-8 μM), autophagy inhibitor 3-methyladenine (100-400 μM) or necrosis inhibitor necrostatin-1 (10-40 μM) had no effect on glutamate induced cell damage. However, the iron chelator deferoxamine mesylate salt inhibited glutamate induced cell death. Thus, the results suggested that ferroptosis is caused by glutamate-induced toxicity and that ferrostatin-1 protects HT-22 cells from glutamate-induced oxidative toxicity by inhibiting the oxidative stress.